Physician profile
Eric M Macy
NPI 1043379670
$2,527.81
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $932 · 2021: $775 · 2022: $669 · 2023: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $481.77 | 2019-2023 | |
| Glaxosmithkline, LLC. | $338.35 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $327.00 | 2021-2022 | |
| Pfizer INC. | $319.63 | 2019-2022 | |
| Grifols USA, LLC | $245.98 | 2021-2023 | Xembify |
| Shire North American Group INC | $134.99 | 2019 | |
| Horizon Therapeutics Plc | $114.59 | 2021 | |
| Grifols Shared Services North America, INC. | $114.43 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $113.61 | 2019 | |
| Genentech USA, INC. | $113.40 | 2019 | |
| Biocryst US Sales Co., LLC | $109.55 | 2021 | |
| Genentech, INC. | $83.41 | 2022 | |
| Spark Therapeutics, INC. | $15.78 | 2022 | |
| Alk-Abello, INC | $15.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Macy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.